USPTO serial 98693300
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Americana Pharma
Houston, TX, US
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietary and nutritional supplements | ACTIVE | — |
| Date | Code | Event |
|---|---|---|
| Aug 18, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Aug 18, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| May 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| May 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| May 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Apr 15, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Jul 15, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Jul 15, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED |
| Jul 15, 2025 | CNSL | SUSPENSION LETTER WRITTEN |
| Jul 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 3, 2025 | ALIE | ASSIGNED TO LIE |
| Jun 19, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Jun 11, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Jun 11, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED |
| Jun 11, 2025 | CNSL | SUSPENSION LETTER WRITTEN |
| Jun 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 4, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 10, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 10, 2025 | GNRT | NON-FINAL ACTION E-MAILED |
| Mar 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN |
| Feb 27, 2025 | DOCK | ASSIGNED TO EXAMINER |
| Feb 26, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Feb 26, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 12, 2024 | NWAP | NEW APPLICATION ENTERED |